- Home
- OPCH vs PBH Comparison
OPCH vs PBH Comparison
Compare OPCH & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OPCH | PBH |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.8B |
| IPO Year | 1996 | 2004 |
Fundamental Metrics
Financial Performance| Metric | OPCH | PBH |
|---|---|---|
| Price | $21.02 | $48.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $36.57 | ★ $75.33 |
| AVG Volume (30 Days) | ★ 3.3M | 787.3K |
| Earning Date | 04-30-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.25 | N/A |
| EPS | 0.29 | ★ 3.91 |
| Revenue | ★ $4,998,202,000.00 | $975,777,000.00 |
| Revenue This Year | $7.21 | N/A |
| Revenue Next Year | $8.55 | $4.31 |
| P/E Ratio | $69.24 | ★ $12.20 |
| Revenue Growth | 16.17 | ★ 36.77 |
| 52 Week Low | $18.01 | $42.62 |
| 52 Week High | $36.80 | $87.06 |
Technical Indicators
Market Signals| Indicator | OPCH | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 45.02 | 47.38 |
| Support Level | $19.34 | $44.51 |
| Resistance Level | $28.92 | $49.21 |
| Average True Range (ATR) | 0.73 | 1.61 |
| MACD | 0.22 | 0.47 |
| Stochastic Oscillator | 46.32 | 81.72 |
Price Performance
Historical ComparisonAbout OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.